The drugmaker’s fastest-growing blockbuster could soon face competition from two biotech firms in the treatment of a little-known heart condition.

We recently published a list of 10 Most Buzzing Stocks To Buy Now. In this article, we are going to take a look at where ...

Pfizer's recent financial performance shows 14% YoY operational growth excluding COVID sales. Check out more on PFE stock ...

One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class ...

NEW YORK (AP) — A mural honoring ancient and modern figures in medicine that has hung in the lobby of Pfizer’s original New ...

Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night. | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on ...

KP.2-adapted COVID-19 vaccine received FDA approval. Manufacturing Optimization Program aims to deliver $1.5b in savings by ...

Pfizer and Valneva may have about two more years to wait before they make the first approval filing to the FDA for a Lyme ...

The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

Pfizer is joining Eli Lilly in making certain of its prescription drugs available directly to consumers, a trend that worries ...

The phase 1/2 Prevnar 20 head-to-head data that Vaxcyte revealed for its VAX-31 in adults ages 50 and older are “exceptional” ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...